HSKA Share Price

Open 95.38 Change Price %
High 97.31 1 Day 1.12 1.17
Low 94.38 1 Week 1.38 1.45
Close 96.52 1 Month 15.52 19.16
Volume 38338 1 Year 69.09 251.88
52 Week High 99.98
52 Week Low 26.25
HSKA Important Levels
Resistance 2 99.24
Resistance 1 98.12
Pivot 96.07
Support 1 94.92
Support 2 93.80
NASDAQ USA Most Active Stocks
FTR 2.11 -10.59%
FTR 2.11 -10.59%
FNFG 10.18 -0.20%
DELL 13.86 0.22%
RFMD 16.59 -2.07%
RIMM 13.03 0.39%
BBEP 0.12 0.00%
GTAT 0.44 0.00%
SUSQ 14.20 -0.77%
ACAS 17.99 0.39%
More..
NASDAQ USA Top Gainers Stocks
LOCM 0.09 50.00%
WRES 0.09 28.57%
BSDM 0.62 26.53%
SNTA 0.34 25.93%
OTT 2.39 25.13%
BGMD 0.06 20.00%
HAUP 0.06 20.00%
IDRA 2.49 19.14%
CLNT 3.08 16.23%
CGEI 0.36 16.13%
More..
NASDAQ USA Top Losers Stocks
TXCC 0.01 -95.00%
HCIIP 10.10 -67.52%
CRMB 0.27 -57.81%
KIOR 0.03 -57.14%
QTWW 0.08 -50.00%
VALV 0.02 -50.00%
OSH 0.26 -49.02%
OSH 0.26 -49.02%
DVOX 0.05 -44.44%
PRXI 0.21 -43.24%
More..

Heska Corporation (NASDAQ: HSKA)

HSKA Technical Analysis 5
As on 22nd Mar 2017 HSKA Share Price closed @ 96.52 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 57.67 & Strong Buy for SHORT-TERM with Stoploss of 83.81 we also expect STOCK to react on Following IMPORTANT LEVELS.
HSKA Target for March
1st Target up-side 102.05
2nd Target up-side 108.58
3rd Target up-side 115.11
1st Target down-side 83.43
2nd Target down-side 76.9
3rd Target down-side 70.37
HSKA Other Details
Segment EQ
Market Capital 44654696.00
Sector Healthcare
Industry Medical Laboratories & Research
Offical website http://www.heska.com
HSKA Address
HSKA
3760 Rocky Mountain Avenue
Loveland, CO 80538
United States
Phone: 970-493-7272
Fax: 970-619-3003
HSKA Latest News
Interactive Technical Analysis Chart Heska Corporation ( HSKA NASDAQ USA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Heska Corporation
HSKA Business Profile
Heska Corporation develops, manufactures, markets, sells and supports veterinary products. The Company is focused on the canine and feline companion animal health markets. It operates in two segments: Core Companion Animal Health and Other Vaccines, Pharmaceuticals and Products. The Core Companion Animal Health segment (CCA) includes diagnostic instruments and supplies, as well as single use diagnostic and other tests, vaccines and pharmaceuticals, primarily for canine and feline use. These products are sold directly by the Company as well as through independent third-party distributors and through other distribution relationships. The Other Vaccines, Pharmaceuticals and Products segment (OVP) includes private label vaccine and pharmaceutical production, primarily for cattle but also for other animals, including small mammals and fish. In February 2013, it announced the acquisition of 54.6% interest of Cuattro Veterinary USA, LLC.